BKB Growth Investments, LLC 3
3 · Verrica Pharmaceuticals Inc. · Filed Jan 26, 2026
Insider Transaction Report
Form 3
BKB Growth Investments, LLC
10% Owner
Holdings
- 3,348,372
Common Stock
Series B Warrants (right to buy)
[F1][F2]Exercise: $1.33Exp: 2029-11-22→ Common Stock (224,719 underlying)Series C Warrants (right to buy)
[F1][F3]Exercise: $6.32Exp: 2030-11-25→ Common Stock (687,690 underlying)
Footnotes (3)
- [F1]Immediately exercisable.
- [F2]The Reporting Person will not be entitled to exercise any portion of a Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 19.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
- [F3]The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 19.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
Signature
BKB Growth Investments, LLC, By: Tiger Lily Capital, LLC, its manager By: /s/ Paul Manning, its manager|2026-01-26